Back
United Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
UTHR
United Therapeutics
Last Price:
$307.41
Seasonality Move:
5.77%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 311.23 | Buy |
20-day SMA: | 311.53 | Buy |
50-day SMA: | 337.65 | Sell |
200-day SMA: | 346.13 | Sell |
8-day EMA: | 310.59 | Buy |
20-day EMA: | 315.8 | Sell |
50-day EMA: | 330.92 | Sell |
200-day EMA: | 331.96 | Sell |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.42 | Sell |
Relative Strength Index (14 RSI): | 44.25 | Sell |
Chaikin Money Flow: | 357508 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (306.83 - 318.05) | Sell |
Bollinger Bands (100): | (327.38 - 380.72) | Sell |
United Therapeutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 312.26 while UTHR 8-day simple moving average is 311.23, which is a Buy signal.
-
The stock price of UTHR is 312.26 while United Therapeutics 20-day SMA is 311.53, which makes it a Buy.
-
United Therapeutics 50-day simple moving average is 337.65 while UTHR share price is 312.26, making it a Sell technically.
-
UTHR stock price is 312.26 and United Therapeutics 200-day simple moving average is 346.13, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a BuyThe current United Therapeutics [UTHR] share price is $312.26. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
14B
Price in USD:
312.26
Share Volume:
461K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
227.75
Buy
55
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 312.26 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 312.26 while UTHR 8-day exponential moving average is 310.59, which is a Buy signal.
-
The stock price of UTHR is 312.26 while United Therapeutics 20-day EMA is 315.80, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 330.92 while UTHR share price is 312.26, making it a Sell technically.
-
UTHR stock price is 312.26 and United Therapeutics 200-day simple moving average is 331.96, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.65 per share, and an increase next year of $0.19 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -7.42, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 44.25, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (306.83 - 318.05), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (327.38 - 380.72), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.